Skip to main content

Marta Ribases Haro

Institutions of which they are part

Main researcher
Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca

Marta Ribases Haro

Institutions of which they are part

Main researcher
Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca

Projects

Impacto del Riesgo Genético Acumulado para el Trastorno por Déficit de Atención con Hiperactividad en las Drogodependencias e identificación de la base genética compartida

IP: Marta Ribases Haro
Collaborators: Montserrat Corrales De la Cruz, Vanesa Richarte Fernández
Funding agency: Instituto de Salud Carlos III
Funding: 123420
Reference: PI17/00289
Duration: 01/01/2018 - 31/12/2020

Microbiota i Factors (Epi)genètics en els trastorns del Neurodesenvolupament: TDAH i Autisme al Llarg de la vida a Catalunya (MENTAL-Cat)

IP: Marta Ribases Haro
Collaborators: Laura Gisbert Gustemps, Christian Fadeuilhe Grau
Funding agency: Generalitat de Catalunya - Departament de Salut
Funding: 145126.8
Reference: SLT006/17/00287
Duration: 01/01/2018 - 31/12/2020

Psiquiatria, Salut Mental i Addiccions

IP: Miquel Casas Brugué
Collaborators: Natalia Calvo Piñero, Carlos Jacas Escarcellé, Montserrat Corrales De la Cruz, Marc Ferrer Vinardell, José Antonio Ramos Quiroga, Lara Grau Lopez, Iris Garcia Martínez, Marta Ribases Haro, Raquel Vidal Estrada, Vanesa Richarte Fernández, Francisco Collazos Sanchez, Maria Soler Artigas
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 35200
Reference: 2017SGR1461
Duration: 01/01/2017 - 30/09/2021

Eat2beNICE: Effects of Nutrition and Lifestyle on Impulsive, Compulsive, and Externalizing behaviors (Grant Nº 728018)

IP: José Antonio Ramos Quiroga
Collaborators: Carolina Ramos Sayalero, Marta Ribases Haro, Christian Fadeuilhe Grau, Silvia Alemany Sierra, Gara Arteaga Henriquez
Funding agency: EUROPEAN COMMISSION
Funding: 479789.91
Reference: EAT2BENICE_H2020-SFS2016
Duration: 01/09/2017 - 28/02/2023

Related news

Irritability in ADHD and BDP is an understudied symptom that has a major impact on patients' quality of life and may even increase the risk of suicide.

These results reinforce the need for more individualized attention to address educational needs from an early stage.

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

Related professionals

David Gurwitz

David Gurwitz

Senior researcher
Systemic Diseases
Read more
SILVIA GARTNER TIZZANO

SILVIA GARTNER TIZZANO

Main researcher
Growth and Development
Read more
Luca Basile

Luca Basile

Administration and Management
Microbiology
Read more
Ana  Leon  Espitia

Ana Leon Espitia

Predoctoral researcher
Research Group of Physical Medicine and Rehabilitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.